Robert Crockart

Glenmark Pharma Gets ANDA approval for Lacosamide Tablets USP

Robert Crockart, Chief Commercial Officer, Glenmark Pharmaceuticals Ltd, said, "The FDA approval for generic Lacosamide Tablets USP reiterates our ongoing commitment to make treatment options more accessible for patients. We look forward to quickly launching this product in the U.S. market."